Welltower (NYSE: HCN) is one of 26 publicly-traded companies in the “Healthcare REITs” industry, but how does it compare to its competitors? We will compare Welltower to related companies based on the strength of its risk, profitability, valuation, analyst recommendations, dividends, institutional ownership and earnings.

Analyst Recommendations

This is a summary of current recommendations for Welltower and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Welltower 2 8 6 0 2.25
Welltower Competitors 207 856 697 12 2.29

Welltower currently has a consensus price target of $72.69, suggesting a potential upside of 5.92%. As a group, “Healthcare REITs” companies have a potential upside of 2.75%. Given Welltower’s higher possible upside, analysts clearly believe Welltower is more favorable than its competitors.

Volatility and Risk

Welltower has a beta of 0.24, meaning that its share price is 76% less volatile than the S&P 500. Comparatively, Welltower’s competitors have a beta of 0.49, meaning that their average share price is 51% less volatile than the S&P 500.


Welltower pays an annual dividend of $3.48 per share and has a dividend yield of 5.1%. Welltower pays out 108.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. As a group, “Healthcare REITs” companies pay a dividend yield of 5.2% and pay out 125.2% of their earnings in the form of a dividend. Welltower has raised its dividend for 7 consecutive years.


This table compares Welltower and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Welltower 28.94% 8.74% 4.39%
Welltower Competitors 37.13% 7.41% 3.64%

Insider & Institutional Ownership

85.9% of Welltower shares are held by institutional investors. Comparatively, 84.2% of shares of all “Healthcare REITs” companies are held by institutional investors. 0.2% of Welltower shares are held by company insiders. Comparatively, 1.9% of shares of all “Healthcare REITs” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Welltower and its competitors top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Welltower $4.19 billion $2.05 billion 21.38
Welltower Competitors $863.81 million $523.61 million 39.28

Welltower has higher revenue and earnings than its competitors. Welltower is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.


Welltower competitors beat Welltower on 8 of the 15 factors compared.

About Welltower

Welltower Inc. invests with seniors housing operators, post-acute providers and health systems to fund real estate and infrastructure. The Company invests in seniors housing and healthcare real estate. It operates in three segments: triple-net, seniors housing operating and outpatient medical. Welltower, a real estate investment trust (REIT), owns interests in properties concentrated in markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities, and outpatient medical properties. Its triple-net properties include independent living facilities, independent supportive living facilities (Canada), continuing care retirement communities, assisted living facilities, care homes with and without nursing (the United Kingdom), Alzheimer’s/dementia care facilities, long-term/post-acute care facilities and hospitals. Its outpatient medical properties include outpatient medical buildings.

Receive News & Ratings for Welltower Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.